002432 Andon Health
- 40.86
- +0.08+0.20%
Andon Health News
Express News | Nearly 2,200 A-share companies have implemented share buybacks this year, with a total amount exceeding 160 billion yuan. Both Hangzhou Hikvision Digital Technology and WUXI APPTEC have buyback amounts surpassing 3 billion yuan.
Express News | Soochow: Assigning an initial rating of buy to Andon Health.
Andon Health (002432): Based on the IHEALTH series, looking forward to the O+O Digital Health.
Investment highlights: The iHealth brand has established a solid foothold in the USA, with the launch of the three-in-one test confirming its leading position. During the outbreak of the Global pandemic in 2020, iHealth quickly launched COVID-19 antigen testing products and secured an Order from the USA government.
Andon health (002432) deep research report: The usa C-end brand power is prominent, and channel reuse is actively expanding categories.
A benchmark for exporting home medical instruments with a deep layout in the usa market. Exporting helps medical instrument companies break through growth ceilings, and among overseas markets, the usa attracts the most attention from companies due to its strong payment capabilities and high entry barriers. Among them, andon health in 2010.
andon health (002432.SZ): accumulated repurchase of 5.96% of shares
Gelonghui November 1st | andon health (002432.SZ) announced that, as of October 31, 2024, the company repurchased a total of 29,226,340 shares through the share buyback special securities account in a centralized auction trading manner, accounting for 5.96% of the company's total share capital. The highest fill price was 41.277 yuan/share, and the lowest fill price was 39.42 yuan/share, with a total payment of RMB 1,179,517,884.38 (excluding transaction costs). This buyback complies with relevant laws and regulations and the company's predetermined buyback plan.
Andon Health (002432.SZ): The iHealth test kit has consistently ranked first in sales among similar products on Amazon.
Jiu'an Health (002432.SZ) stated at an investor relations event on November 1st that the company actively layout online and offline sales channels, and the sales volume of test kits performed well. The iHealth test kit continues to rank first in sales among similar products on Amazon, with far higher reviews than similar products. The three-combination test kits also maintain the top position among similar products.
Andon Health's Q3 Profit Soars 591%
Jiu\'an Healthcare: Report for the third quarter of 2024
Express News | Andon Health: net income in the third quarter increased by 591.41% year-on-year
Andon Health (002432.SZ): The net income in the first three quarters was 1.369 billion yuan, a year-on-year increase of 52.63%.
Gelonghui, October 30th - Andon Health (002432.SZ) announced its third quarter report for 2024, achieving revenue of 2.092 billion yuan for the first three quarters, a decrease of 23.79% year-on-year; net income attributable to shareholders of the listed company was 1.369 billion yuan, an increase of 52.63% year-on-year; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 1.377 billion yuan, an increase of 100.83% year-on-year; and the basic earnings per share was 3.1866 yuan.
Express News | Andon Health: The successful launch of the Andon One Satellite.
Express News | Andon Health establishes a new company, including sales business for navigation terminals.
Andon Health (002432.SZ): has repurchased 5.96% of shares.
格隆汇September 2nd | Andon Health (002432.SZ) announced that as of August 31, 2024, the company repurchased a total of 29,226,340 shares through the share buyback special securities account in a centralized auction trading manner, accounting for 5.96% of the total share capital of the company. The highest fill price was 41.277 yuan per share, the lowest fill price was 39.42 yuan per share, and the total amount paid was RMB 1.18 billion (excluding transaction costs).
Jiu\'an Healthcare: 2024 Semi-Annual Report
Jiu\'an Healthcare: 2024 Semi-Annual Report Summary
Andon Health (002432.SZ): The net income in the first half of the year was 0.602 billion yuan, a year-on-year decrease of 23.42%.
Andon Health(002432.SZ) announced its semi-annual report for 2024, with a revenue of 1.351 billion yuan, a year-on-year decrease of 40.82%; a net income attributable to shareholders of listed companies of 0.602 billion yuan, a year-on-year decrease of 23.42%; a net income attributable to shareholders of listed companies excluding non-recurring gains and losses of 0.698 billion yuan, a year-on-year increase of 42.36%; and an earnings per share of 1.3788 yuan.
Express News | Andon Health: net income in the first half of 2024 was 0.602 billion yuan, a year-on-year decrease of 23.42%.
Express News | Andon Health establishes a new subsidiary including the business of new energy vehicle sales.
Andon Health (002432.SZ) plans to launch an employee stock ownership plan in 2024, with a total fundraising amount not exceeding 0.445 billion yuan.
On August 16th, Gelonhui reported that Andon Health (002432.SZ) announced the employee stock ownership plan (draft) for 2024. The stock source of this employee stock ownership plan comes from the repurchased shares in the company's repurchase account. This employee stock ownership plan plans to hold no more than 21,700,000 shares of the target stock, accounting for 4.42% of the total share capital of the company. The total amount of funds to be raised by this employee stock ownership plan is no more than 0.445 billion yuan, with 'shares' as the subscription unit, and the initial subscription price of each share is 1.00 yuan. The upper limit of shares is 445,067,000 shares at the time of establishment. In order to meet the sustainable development of the company.
The medical device sector of A shares surged, with Improve Medical Instruments rising more than 15%.
On August 12th, Improve Medical Instruments rose more than 15%, while Andon Health, Jiangsu Yuyue Medical Equipment & Supply, Guangdong Transtek Medical Electronics, Ningbo David Medical Device followed suit.
No Data
